Medimmune Limited

Nancy Ulbrandt

Nicole Kallewaard-LeLay

Andy Q Yuan

Bettina Richter

Nicole Kallewaard-Lelay

This application provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, as well as means and methods for producing them.

RSV-specific antibodies and functional parts thereof

Respiratory Syncytial Virus is a common cold virus belonging to the family of paramyxovirus. RSV is virulent, easily transmissible and the most common cause of lower respiratory tract disease in children of less than 2 years of age. Up to 98% of children attending day care will be infected in a single RSV season. Between 0.5% and 3.2% of children with RSV infection require hospitalization. Approximately 90,000 hospital admissions and 4500 deaths per year were reported in United States. Major risk factors for hospitalization due to RSV are premature birth, chronic lung disease, congenital heart disease, compromised immunity, and age younger than 6 weeks in otherwise healthy children.

Growing community of inventors

Gaithersburg, MD, United States of America

Nancy Ulbrandt